Li Huang , Hongyang Liu , Kunli Zhang , Qingwen Meng , Liang Hu , Yuanfeng Zhang , Zhida Xiang , Jiangnan Li, Yuying Yang , Yali Chen , Shangjin Cui , Hong Tang , Huadong Pei , Zhigao Bu , Changjiang Weng 

Cell Rep. 2020 Aug 18;32(7):108044.doi: 10.1016/j.celrep.2020.108044.

Abstract

Type I interferon (IFN) plays an essential role in the host innate immune responses. Several ubiquitin-conjugating enzyme (E2) family members were reported to regulate type I IFN production and host antiviral immune responses. However, the molecular mechanisms are still not fully understood. Here, we report that UBE2S acts as a negative regulator in the type I IFN signaling pathway. Ectopic expression of UBE2S inhibits host antiviral immune responses and enhances viral replications, whereas deficiency of UBE2S enhances host antiviral immune responses and suppresses viral replications both in vitro and in vivo. Inhibition of type І IFN production by UBE2S is independent on its E2 and E3 enzymic activity. Mechanistically, UBE2S interacts with TBK1 and recruits ubiquitin-specific protease 15 (USP15) to remove Lys63 (K63)-linked polyubiquitin chains of TBK1. Our findings reveal a role of the UBE2S-USP15-TBK1 axis in the regulation of host antiviral innate immune responses.

Keywords: IFN; TBK1; UBE2S; USP15; deubiquitination; knockout; transgenic mouse.

Copyright © 2020 Harbin Veterinary Research Institute. Published by Elsevier Inc. All rights reserved.